*	OR T1 T2
*	OR T3 T4
R1	Has_temporal Arg1:T1 Arg2:T3	
*	OR T6 T8 T7
*	OR T14 T15
R2	Has_qualifier Arg1:T13 Arg2:T12	
*	OR T10 T11 T13
R3	Has_qualifier Arg1:T10 Arg2:T9	
R4	Has_temporal Arg1:T10 Arg2:T14	
R5	Has_qualifier Arg1:T19 Arg2:T18	
*	OR T20 T21
R6	Has_mood Arg1:T19 Arg2:T17	
*	OR T10 T19
R7	Has_temporal Arg1:T19 Arg2:T20	
R8	Has_index Arg1:T24 Arg2:T25	
R9	Has_qualifier Arg1:T23 Arg2:T22	
R10	Has_temporal Arg1:T23 Arg2:T24	
R11	Has_qualifier Arg1:T27 Arg2:T26	
R12	multi Arg1:T26 Arg2:T28	
R13	Has_temporal Arg1:T34 Arg2:T35	
*	OR T31 T32
R14	Has_temporal Arg1:T33 Arg2:T31	
R15	AND Arg1:T33 Arg2:T34	
R16	Has_qualifier Arg1:T30 Arg2:T29	
R17	Has_index Arg1:T35 Arg2:T39	
R18	Subsumes Arg1:T30 Arg2:T33	
R20	Has_qualifier Arg1:T42 Arg2:T41	
R21	Has_qualifier Arg1:T42 Arg2:T40	
R19	Has_value Arg1:T43 Arg2:T44	
R22	AND Arg1:T45 Arg2:T43	
R23	Has_qualifier Arg1:T47 Arg2:T46	
R24	Has_qualifier Arg1:T52 Arg2:T51	
R25	Has_temporal Arg1:T52 Arg2:T50	
*	OR T49 T52
R26	Has_index Arg1:T53 Arg2:T54	
R27	Has_temporal Arg1:T49 Arg2:T53	
*	OR T58 T59
R28	Has_value Arg1:T58 Arg2:T57	
R29	Has_qualifier Arg1:T63 Arg2:T62	
R30	Has_temporal Arg1:T63 Arg2:T61	
R31	multi Arg1:T66 Arg2:T65	
R32	multi Arg1:T67 Arg2:T68	
*	OR T70 T71
*	OR T69 T70
*	OR T76 T77
R34	AND Arg1:T77 Arg2:T78	
R33	AND Arg1:T72 Arg2:T75	
R35	Subsumes Arg1:T69 Arg2:T72	
R36	Subsumes Arg1:T80 Arg2:T81	
R37	multi Arg1:T84 Arg2:T85	
*	OR T82 T83
R38	Has_temporal Arg1:T82 Arg2:T84	
*	OR T87 T88
*	OR T93 T94
R39	Has_negation Arg1:T93 Arg2:T92	
R40	Has_negation Arg1:T91 Arg2:T92	
R41	Has_index Arg1:T3 Arg2:T4	
R42	Has_index Arg1:T14 Arg2:T15	
R43	Has_index Arg1:T20 Arg2:T21	
R44	Has_temporal Arg1:T56 Arg2:T53	
T1	Procedure 0 16	Systemic therapy
T2	Procedure 20 32	radiotherapy
T3	Temporal 33 62	within 4 weeks prior to Day 1
T4	Reference_point 57 62	Day 1
T6	Temporal 64 69	Prior
T7	Procedure 70 77	therapy
T8	Drug 83 125	agents targeting the DR5 apoptosis pathway
T9	Qualifier 127 132	Major
T10	Procedure 133 151	surgical procedure
T11	Procedure 153 164	open biopsy
T12	Qualifier 169 180	significant
T13	Condition 181 197	traumatic injury
T14	Temporal 198 227	within 4 weeks prior to Day 1
T15	Reference_point 222 227	Day 1
T17	Mood 232 252	anticipation of need
T18	Qualifier 257 262	major
T19	Procedure 263 281	surgical procedure
T20	Temporal 282 312	during the course of the study
T21	Reference_point 303 312	the study
T22	Qualifier 314 319	Other
T23	Condition 320 341	invasive malignancies
T24	Temporal 342 371	within 5 years prior to Day 1
T25	Reference_point 366 371	Day 1
T26	Qualifier 379 385	active
T27	Condition 386 402	brain metastases
T28	Temporal 379 385	active
T29	Qualifier 404 416	Uncontrolled
T30	Condition 417 437	intercurrent illness
T31	Temporal 468 475	ongoing
T32	Qualifier 479 485	active
T33	Condition 486 495	infection
T34	Drug 506 528	parenteral antibiotics
T35	Temporal 529 542	at enrollment
T39	Reference_point 532 542	enrollment
T40	Qualifier 544 566	Clinically significant
T41	Qualifier 568 579	symptomatic
T42	Condition 580 602	cardiovascular disease
T43	Measurement 604 637	New York Heart Association (NYHA)
T44	Value 638 657	Grade II or greater
T45	Condition 658 682	congestive heart failure
T46	Qualifier 684 691	serious
T47	Condition 692 710	cardiac arrhythmia
T48	Value 712 731	Grade II or greater
T49	Condition 732 759	peripheral vascular disease
T50	Temporal 764 774	history of
T51	Qualifier 775 780	major
T52	Procedure 781 794	heart surgery
T53	Temporal 795 819	within 6 months of Day 1
T54	Reference_point 814 819	Day 1
T56	Observation 856 872	limit compliance
T57	Value 910 918	positive
T58	Measurement 923 934	hepatitis C
T59	Measurement 938 965	hepatitis B surface antigen
T61	Temporal 967 974	History
T62	Qualifier 978 983	other
T63	Condition 984 991	disease
T64	Condition 993 1014	metabolic dysfunction
T65	Procedure 1016 1036	physical examination
T66	Condition 1016 1044	physical examination finding
T67	Condition 1049 1076	clinical laboratory finding
T68	Procedure 1049 1068	clinical laboratory
T69	Mood 1095 1107	suspicion of
T70	Condition 1110 1117	disease
T71	Condition 1121 1130	condition
T72	Condition 1136 1151	contraindicates
T75	Drug 1162 1182	investigational drug
T76	Observation 1197 1233	affect interpretation of the results
T77	Observation 1250 1281	render the patient at high risk
T78	Condition 1286 1309	treatment complications
T80	Procedure 1318 1341	anticoagulation therapy
T81	Drug 1318 1333	anticoagulation
T82	Observation 1343 1375	Participation in clinical trials
T83	Observation 1379 1422	undergoing other investigational procedures
T84	Temporal 1423 1452	within 30 days prior to Day 1
T85	Reference_point 1438 1452	prior to Day 1
T87	Condition 1454 1463	Pregnancy
T88	Observation 1467 1481	breast feeding
T89	Condition 1489 1500	sensitivity
T90	Drug 1504 1553	any of the products administered during the study
T91	Condition 1559 1567	disorder
T92	Negation 1573 1599	compromises the ability of
T93	Measurement 1615 1644	give written informed consent
T94	Procedure 1652 1680	comply with study procedures
